PROMETHEUS BIOSCIENCES, INC. Other Income and Expense
PROMETHEUS BIOSCIENCES, INC. reported Other Income and Expense of $7.83 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. nonoperating income (expense) for the quarter ending 2023-03-31 was $7.83M, a 25993.33% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. nonoperating income (expense) for the quarter ending 2022-12-31 was $2.57M, a 9769.23% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. nonoperating income (expense) for the quarter ending 2022-09-30 was $1.11M.
- PROMETHEUS BIOSCIENCES, INC. nonoperating income (expense) for the quarter ending 2022-06-30 was $321.00K.
- PROMETHEUS BIOSCIENCES, INC. nonoperating income (expense) for fiscal 2022 was $4.03M.
- PROMETHEUS BIOSCIENCES, INC. nonoperating income (expense) for fiscal 2021 was -$2.39M.
- PROMETHEUS BIOSCIENCES, INC. nonoperating income (expense) for fiscal 2020 was -$2.13M.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2023-03-31 | $7.83M 10-Q · filed 2023-05-09 | $10.39M derived: sum of 2 quarters · filed 2023-05-09 | $11.50M derived: sum of 3 quarters · filed 2023-05-09 | $11.82M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $3.67M derived: sum of 2 quarters · filed 2023-02-28 | $4.00M derived: sum of 3 quarters · filed 2023-02-28 | $4.03M 10-K · filed 2023-02-28 |
| 2022-09-30 | $1.11M 10-Q · filed 2022-11-09 | $1.43M derived: sum of 2 quarters · filed 2022-11-09 | $1.46M 10-Q · filed 2022-11-09 | $1.49M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | $321.00K 10-Q · filed 2022-08-11 | $352.00K 10-Q · filed 2022-08-11 | $377.00K derived: sum of 3 quarters · filed 2023-05-09 | -$163.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | $30.00K 10-Q · filed 2023-05-09 | $56.00K derived: sum of 2 quarters · filed 2023-05-09 | -$484.00K derived: sum of 3 quarters · filed 2023-05-09 | -$637.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$514.00K derived: sum of 2 quarters · filed 2023-02-28 | -$667.00K derived: sum of 3 quarters · filed 2023-02-28 | -$2.39M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$540.00K 10-Q · filed 2022-11-09 | -$693.00K derived: sum of 2 quarters · filed 2022-11-09 | -$2.42M 10-Q · filed 2022-11-09 | -$3.06M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$153.00K 10-Q · filed 2022-08-11 | -$1.88M 10-Q · filed 2022-08-11 | -$2.52M derived: sum of 3 quarters · filed 2023-02-28 | -$2.88M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$1.73M 10-Q · filed 2022-05-12 | -$2.37M derived: sum of 2 quarters · filed 2023-02-28 | -$2.73M derived: sum of 3 quarters · filed 2023-02-28 | -$3.33M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$645.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$1.00M derived: sum of 2 quarters · filed 2023-02-28 | -$1.60M derived: sum of 3 quarters · filed 2023-02-28 | -$2.13M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$360.00K 10-Q · filed 2021-11-12 | -$957.00K derived: sum of 2 quarters · filed 2021-11-12 | -$1.49M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$597.00K 10-Q · filed 2021-08-11 | -$1.13M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | -$530.00K 10-Q · filed 2021-05-13 |